Cart
sales@molnova.com
FR 180204
CAS No. 865362-74-9
FR 180204 ( FR180204;FR-180204 )
Catalog No. M16283 CAS No. 865362-74-9
FR 180204 is a potent, selective, ATP-competitive ERK inhibitor with Ki of 0.31 and 0.14 uM for ERK1 and ERK2, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 70 | In Stock |
|
| 10MG | 126 | In Stock |
|
| 25MG | 210 | In Stock |
|
| 50MG | 314 | In Stock |
|
| 100MG | 471 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFR 180204
-
NoteResearch use only, not for human use.
-
Brief DescriptionFR 180204 is a potent, selective, ATP-competitive ERK inhibitor with Ki of 0.31 and 0.14 uM for ERK1 and ERK2, respectively.
-
DescriptionFR 180204 is a potent, selective, ATP-competitive ERK inhibitor with Ki of 0.31 and 0.14 uM for ERK1 and ERK2, respectively; inhibits TGFβ-induced luciferase-expression in mink lung epithelial Mv1Lu cells, decreases plasma anti-CII antibody levels and attenuates delayed-type hypersensitivity in CII-immunized DBA/1 mice, also inhibits in vitro CII-induced proliferation of lymph node cells prepared from CII-immunized mice; enhances apoptotic and anti-proliferative effects of Akt inhibitor API-1 in human DLD-1 and LoVo colorectal cancer cells.
-
SynonymsFR180204;FR-180204
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK1;ERK2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number865362-74-9
-
Formula Weight327.34
-
Molecular FormulaC18H13N7
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 50 mg/mL
-
SMILESNC1=NNC2=NN=C(C3=C4C=CC=CN4N=C3C5=CC=CC=C5)C=C21
-
Chemical Name1H-Pyrazolo[3,4-c]pyridazin-3-amine, 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ohori M, et al. Biochem Biophys Res Commun. 2005 Oct 14;336(1):357-63.
2. Ohori M, et al. Naunyn Schmiedebergs Arch Pharmacol.
3. Chen-Roetling J, et al. Neuropharmacology. 2009 Apr;56(5):922-8.
4. Saglam AS, et al. Oncol Lett. 2016 Oct;12(4):2463-2474.
2. Ohori M, et al. Naunyn Schmiedebergs Arch Pharmacol.
3. Chen-Roetling J, et al. Neuropharmacology. 2009 Apr;56(5):922-8.
4. Saglam AS, et al. Oncol Lett. 2016 Oct;12(4):2463-2474.
molnova catalog
related products
-
ERK-IN-3
ERK-IN-3 is a potent and orally active inhibitor of ERK. It inhibits ERK1/2 with low single-digit nM IC50 values. It can be used for the research of cancers driven by RAS mutations.
-
Muramyl dipeptide
Muramyl dipeptide is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln.
-
NVP 231
NVP-231 is a potent, specific, and reversible CerK inhibitor(IC50=12±2 nM) that competitively inhibits binding of ceramide to CerK.
